Cargando…

Early Assessment of the Efficacy of Temozolomide Chemotherapy in Experimental Glioblastoma Using [(18)F]FLT-PET Imaging

Addition of temozolomide (TMZ) to radiation therapy is the standard treatment for patients with glioblastoma (GBM). However, there is uncertainty regarding the effectiveness of TMZ. Considering the rapid evolution of the disease, methods to assess TMZ efficacy early during treatment would be of grea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viel, Thomas, Schelhaas, Sonja, Wagner, Stefan, Wachsmuth, Lydia, Schwegmann, Katrin, Kuhlmann, Michael, Faber, Cornelius, Kopka, Klaus, Schäfers, Michael, Jacobs, Andreas H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701682/ https://www.ncbi.nlm.nih.gov/pubmed/23861829 http://dx.doi.org/10.1371/journal.pone.0067911

Ejemplares similares

Voxel-Based Analysis of the Relation of 3′-Deoxy-3′-[(18)F]fluorothymidine ([(18)F]FLT) PET and Diffusion-Weighted (DW) MR Signals in Subcutaneous Tumor Xenografts Does Not Reveal a Direct Spatial Relation of These Two Parameters
por: Schelhaas, Sonja, et al.
Publicado: (2021)

Short-Term Colony-Stimulating Factor 1 Receptor Inhibition–Induced Repopulation After Stroke Assessed by Longitudinal (18)F-DPA-714 PET Imaging
por: Barca, Cristina, et al.
Publicado: (2022)

Multimodal imaging reveals temporal and spatial microglia and matrix metalloproteinase activity after experimental stroke
por: Zinnhardt, Bastian, et al.
Publicado: (2015)

A Longitudinal PET/MRI Study of Colony-Stimulating Factor 1 Receptor–Mediated Microglia Depletion in Experimental Stroke
por: Barca, Cristina, et al.
Publicado: (2022)

Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined (18)F-FDG and (18)F-FLT PET/CT imaging
por: Sachpekidis, C., et al.
Publicado: (2018)

Extramedullary haematopoiesis imaging with (18)F-FLT PET
por: Agool, Ali, et al.
Publicado: (2010)

Impact of hydroxytyrosol on stroke: tracking therapy response on neuroinflammation and cerebrovascular parameters using PET-MR imaging and on functional outcomes
por: Barca, Cristina, et al.
Publicado: (2021)

The relationship between endogenous thymidine concentrations and [(18)F]FLT uptake in a range of preclinical tumour models
por: Heinzmann, Kathrin, et al.
Publicado: (2016)

(18)F-FLT PET/CT in Patients with Gastric Carcinoma
por: Małkowski, Bogdan, et al.
Publicado: (2013)

Correction to: The relationship between endogenous thymidine concentrations and [(18)F]FLT uptake in a range of preclinical tumour models
por: Heinzmann, Kathrin, et al.
Publicado: (2017)

Distortion correction of MR data in whole-body small animal PET-MR using 3D thin-plate splines
por: Frohwein, Lynn, et al.
Publicado: (2014)

An Intra-Individual Comparison of MRI, [(18)F]-FET and [(18)F]-FLT PET in Patients with High-Grade Gliomas
por: Nowosielski, Martha, et al.
Publicado: (2014)

Insight into the dynamics, localization and magnitude of antigen-specific immune responses by [(18)F]FLT PET imaging
por: Aarntzen, Erik H.J.G., et al.
Publicado: (2012)

Limits of [(18)F]-FLT PET as a Biomarker of Proliferation in Oncology
por: McKinley, Eliot T., et al.
Publicado: (2013)

Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, (18)F-FMISO PET, and (18)F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma
por: Collet, Solène, et al.
Publicado: (2021)

Imaging temozolomide-induced changes in the myeloid glioma microenvironment
por: Foray, Claudia, et al.
Publicado: (2021)

A Pilot Study of 18F-FLT PET/CT in Pediatric Lymphoma
por: Costantini, Danny L., et al.
Publicado: (2016)

Impact of [(18)F]FDG-PET and [(18)F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer
por: Christensen, Tine N., et al.
Publicado: (2021)

Towards Optimized Bioavailability of (99m)Tc-Labeled Barbiturates for Non-invasive Imaging of Matrix Metalloproteinase Activity
por: Honold, Lisa, et al.
Publicado: (2021)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Synthesis and biological evaluation of PET tracers designed for imaging of calcium activated potassium channel 3.1 (K(Ca)3.1) channels in vivo
por: Brömmel, Kathrin, et al.
Publicado: (2021)

Noninvasive quantification of (18)F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma
por: Backes, Heiko, et al.
Publicado: (2009)

Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells
por: Beltzig, Lea, et al.
Publicado: (2022)

Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
por: Strobel, Hannah, et al.
Publicado: (2019)

(18)F-FLT PET/CT imaging in a Wister rabbit inflammation model
por: TAN, YEYING, et al.
Publicado: (2014)

Intermittent dosing of axitinib combined with chemotherapy is supported by (18)FLT-PET in gastrointestinal tumours
por: Hoh, C K, et al.
Publicado: (2014)

(18)F-FLT PET/MRI for bone marrow failure syndrome-initial experience
por: Tsujikawa, Tetsuya, et al.
Publicado: (2019)

Considering the Experimental Use of Temozolomide in Glioblastoma Research
por: Herbener, Verena J., et al.
Publicado: (2020)

LAPTM5–CD40 Crosstalk in Glioblastoma Invasion and Temozolomide Resistance
por: Berberich, Anne, et al.
Publicado: (2020)

Diagnostic performance of (18)F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer
por: Rahbar, Kambiz, et al.
Publicado: (2018)

Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016)

Strategies of temozolomide in future glioblastoma treatment
por: Lee, Chooi Yeng
Publicado: (2017)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
por: Saha, Dipongkor, et al.
Publicado: (2020)

The impact of vasomotion on analysis of rodent fMRI data
por: Lambers, Henriette, et al.
Publicado: (2023)

Cost-Effectiveness of [(18)F] Fluoroethyl-L-Tyrosine for Temozolomide Therapy Assessment in Patients With Glioblastoma
por: Baguet, Tristan, et al.
Publicado: (2019)

Syntheses of Radioiodinated Pyrimidine-2,4,6-Triones as Potential Agents for Non-Invasive Imaging of Matrix Metalloproteinases
por: Breyholz, Hans-Jörg, et al.
Publicado: (2017)

Molecular Imaging of Immune Cell Dynamics During De- and Remyelination in the Cuprizone Model of Multiple Sclerosis by [(18)F]DPA-714 PET and MRI
por: Zinnhardt, Bastian, et al.
Publicado: (2019)

PET Cell Tracking Using (18)F-FLT is Not Limited by Local Reuptake of Free Radiotracer
por: MacAskill, Mark G., et al.
Publicado: (2017)

Glucose Influences the Response of Glioblastoma Cells to Temozolomide and Dexamethasone
por: Bielecka-Wajdman, Anna M, et al.
Publicado: (2022)

NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma
por: Sim, Hao-Wen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b31ph6fbealf5t8npsgat8r9ss